Immune to Cancer: The CRI Blog
-
AACR17 Update: Checkpoint Immunotherapy Clinical Trials in Melanoma and Lung Cancer
In-depth analysis of long-term clinical trial data provides important insights for doctors treating…
-
AACR17 Update: Checkpoints, Vaccines, and the Power of Prediction
Day 3 at AACR17 highlighted the importance of immune memory and personalized approaches…
-
AACR17 Update: CAR T Cells, Regulatory T Cells, and the Future of Immunotherapy
Day two addressed several strategies to improve immunotherapy’s precision and effectiveness
-
AACR17 Update: Taking Immunotherapy to the Next Level
After cancer immunotherapy’s initial successes, new challenges are being confronted
-
AACR17: Immunotherapy’s Impact on the Future of Cancer Treatment
Dozens of CRI scientists to highlight the latest immunotherapy breakthroughs during five-day conference in nation’s capital.
-
Financing Better Cancer Treatments
Inlanta Mortgage again chose CRI to be the beneficiary at their annual conference raffle.
-
Thèrése B’s Immunotherapy Story
Melanoma I’m amazed I’m still alive because I know how terrible a disease it is. Thèrése’s Story… -
Sergei G’s Immunotherapy Story
Lymphoma The whole procedure is very well orchestrated…it’s almost like a CIA exploration. Sergei’s Story When doctors… -
Kay Ellen G’s Immunotherapy Story
Ovarian Cancer I was much stronger than I thought. Kay Ellen’s Story Everyone needs an advocate sometimes….
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.